The menopause and osteoporosis

Obstetrics and Gynecology

Volumn 87, Issue 2 II SUPPL., 1996, Pages

  Lindsay, Robert ^a  

^a HELEN HAYES HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; ETIDRONIC ACID; FLUORIDE SODIUM; GESTAGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RALOXIFENE;

AGING; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE REMODELING; BREAST CANCER; CLINICAL TRIAL; ENDOMETRIUM HYPERPLASIA; ESTROGEN DEFICIENCY; FEMALE; HIP FRACTURE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MENOPAUSE; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; PATHOLOGIC FRACTURE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; VERTEBRA FRACTURE;

EID: 0030069939     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00430-0     Document Type: Article

References (21)

1. Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis. JAMA 1941;116:2465-74.
2. Anonymous. Consensus development conference: Osteoporosis. Am J Med 1991;90:107-10.
3. Lindsay R. The burden of osteoporosis: Cost. Am J Med 1995;98: S9-11.
4. Melton LJ III, Lane AW, Cooper C, Eastell R, O'Fallon WM, Riggs BL. Prevalence and incidence of vertebral deformities. Osteo Int 1993;3:113-9.
5. Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: A world-wide projection. Osteo Int 1992;2:285-9.
6. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fractures in white women. Study of osteoporotic fractures research group. N Engl J Med 1995;332:767-73.
7. Tohme J, Cosmn F, Lindsay R. Osteoporosis. In: Becker KL, ed. Principles and practices of endocrinology and metabolism. 2nd ed. JB Lippincott, 1995:567-85.
8. Dempster DW, Lindsay R. Pathogenesis of osteoporosis. Lancet 1993;341:797-801.
9. Johnston CC, Melton LJ III, Lindsay R, Eddy DM. Clinical indications for bone mass measurement. J Bone Miner Res 1989;4(suppl 2):1-28.
10. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. Geneva: World Health Organization. (WHO technical report series no. 843, 1994.)
11. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72-5.
12. Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 1989;10:313-20.
13. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980;ii:1151-4.
14. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759-63.
15. Lindsay R, Hart DM, MacLean A, Clark AC, Kraszewski A, Garwood J. Bone response to termination of oestrogen treatment. Lancet 1978;i:1325-7.
16. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-6.
17. Eriksen EF, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241: 84-6.
18. Gennari C, Avioli LV. Calcitonin therapy in osteoporosis. In: Avioli LV, ed. The osteoporotic syndrome. 2nd ed. New York: Grune and Stratton, 1987:121-43.
19. Fleish H. Bisphosphonates in bone disease. From the laboratory to the patient. Berne: Stampfli and Co, 1993.
20. Turken S, Siris E, Seldin D, Lindsay R. Effects of tamoxifen on spinal bone density. J Natl Cancer Inst 1989;81:1086-8.
21. Draper MW, Flowers DE, Huster WJ, Neild JA. Effects of raloxifene (LY139481 HCI) on biochemical markers of bone and lipid metabolism in healthy postmenopausal women. In: Christiansen C, Riis BJ, eds. Osteoporosis. Proceedings of the Fourth International Symposium on Osteoporosis, Copenhagen, 1993;119-21.